All In Biotech

Free tool

FAERS Monitor: Invega Hafyera

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 207946 or its brand name (Invega Hafyera, Paliperidone Palmitate). Reports on generic versions are filed under their own applications.

Reports

8,538

Serious

5,139

60% of reports

Hospitalization

2,454

Death reported

599

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective842
  • off label use790
  • hospitalisation646
  • schizophrenia556
  • condition aggravated508
  • product dose omission issue407
  • therapeutic response decreased342
  • death319
  • psychotic disorder317
  • weight increased307
  • suicide attempt264
  • dyskinesia260
  • sedation260
  • hallucination, auditory244
  • inappropriate schedule of product administration238

Reports by year received

View as table
YearReports
20062
20071
20081
20095
20107
201115
201276
201374
201449
2015126
2016445
2017769
2018609
2019609
2020504
2021592
20221,262
20231,107
2024962
2025786
2026537

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,621 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
schizophreniaSignal556118.1108.761,516
hallucination, auditorySignal24438.433.98,722
psychotic disorderSignal31726.724.07,751
sedationSignal26024.721.95,835
dyskinesiaSignal26015.914.13,588
therapeutic response decreasedSignal34214.012.64,094
suicide attemptSignal26410.89.62,326
hospitalisationSignal64610.49.75,494
condition aggravatedSignal5084.13.81,213
product dose omission issueSignal4073.43.1701
weight increasedSignal3073.43.0517
inappropriate schedule of product administrationSignal2383.32.9373
off label useSignal7902.22.1553
drug ineffective8421.61.5187
death3190.90.83

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.